放射性ヨード内服により生じたと考えられる口腔乾燥症の1例

書誌事項

タイトル別名
  • A case of xerostomia caused by exposure to radioactive iodine
  • ホウシャセイ ヨード ナイフク ニ ヨリ ショウジタ ト カンガエラレル コウコウ カンソウショウ ノ 1レイ

この論文をさがす

抄録

Oral radioiodine (131I) therapy is known to be an effective treatment for differentiated thyroid carcinoma, but it can cause salivary gland impairment. We report a case of xerostomia caused by oral radioiodine therapy for thyroid cancer.<br>A 47-year-old woman consulted our hospital because of tongue pain accompanied by xerostomia. The patient had a history of receiving radioiodine therapy for metastatic thyroid carcinoma 3 times (total 9,990 MBq). Clinical examination demonstrated oral dryness and reduced salivary gland function. On the gum test, the salivary flow was 2 ml in 6 minutes. It was hard to continue chewing for more than 6 minutes because of irritation. A computed tomographic scan showed atrophic changes of both parotid glands. On radioiodine whole-body imaging, uptake of radioiodine was evident in both the parotid and submandibular glands. Based on these findings, xerostomia caused by salivary gland injury due to radioiodine therapy was clinically diagnosed. The salivary gland injury was irreversible, and the patient received symptomatic therapy and pilocarpine hydrochoride. Early intervention to avoid salivary gland injury is important in patients who receive radioactive iodine therapy.

収録刊行物

参考文献 (10)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ